When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AVRO - Avrobio rallies on gene therapy data in Fabry
AVROBIO Inc.
Thinly traded AVROBIO (NASDAQ:AVRO) jumps 4% premarket on light volume in reaction to updated data from a Phase 2 study evaluating its AVR-RD-01 gene therapy in patients with Fabry disease, an inherited disorder characterized by the buildup of a type of fat in the body's cells due to the the dysfunction or absence of a key enzyme called alpha-galactosidase A (AGA). The results are being presented today at the American Society of Gene & Cell Therapy Annual Meeting.
More news on: AVROBIO, Inc., Healthcare stocks news, Stocks on the move,